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Abstract
Current molecular diagnostic techniques for susceptibility testing of septicemia rely on genotyping for the presence of
known resistance cassettes. This technique is intrinsically vulnerable due to the inability to detect newly emergent
resistance genes. Traditional phenotypic susceptibility testing has always been a superior method to assay for resistance;
however, relying on the multi-day growth period to determine which antimicrobial to administer jeopardizes patient
survival. These factors have resulted in the widespread and deleterious use of broad-spectrum antimicrobials. The real-time
PCR antibiogram, described herein, combines universal phenotypic susceptibility testing with the rapid diagnostic
capabilities of PCR. We have developed a procedure that determines susceptibility by monitoring pathogenic load with the
highly conserved 16S rRNA gene in blood samples exposed to different antimicrobial drugs. The optimized protocol
removes heme and human background DNA from blood, which allows standard real-time PCR detection systems to be
employed with high sensitivity (,100 CFU/mL). Three strains of E. coli, two of which were antimicrobial resistant, were
spiked into whole blood and exposed to three different antibiotics. After real-time PCR-based determination of pathogenic
load, a DCt,3.0 between untreated and treated samples was found to indicate antimicrobial resistance (P,0.01). Minimum
inhibitory concentration was determined for susceptible bacteria and pan-bacterial detection was demonstrated with 3
Gram-negative and 2 Gram-positive bacteria. Species identification was performed via analysis of the hypervariable
amplicons. In summary, we have developed a universal diagnostic phenotyping technique that assays for the susceptibility
of drug-resistant septicemia with the speed of PCR. The real-time PCR antibiogram achieves detection, susceptibility testing,
minimum inhibitory concentration determination, and identification in less than 24 hours.
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Introduction
Current molecular diagnostic technologies for septicemia have
primarily focused on pathogen identification as a means to
optimize antimicrobial therapy for patients. Such developments
have included multiplexed PCR [1,2], microarray platforms [3,4],
and chemiluminescent RNA probes [5] for the genetic detection of
known bacterial and fungal organisms responsible for septicemia.
Virulence and susceptibility are often deduced upon species
identification as only a handful of known resistance genes can be
screened with current commercial systems [2]. Compounding the
issue of genotyping for resistance is the fact that the number of
potential resistance genes scale with each pathogen, thus straining
the limits of current diagnostic technology and economic feasi-
bility. Despite this constraint, molecular diagnostic systems have
demonstrated species identification in less than 24 hours, a drastic
improvement in comparison to the gold standard culture-based
susceptibility and Gram staining-based identification methods that
yield results in 24 to 72 hours [3,4,6,7]. However, even though
literature agrees that molecular diagnostic detection rapidly
decreases the time to sepsis diagnosis, much debate over the
accuracy of pathogen identification and hence, the appropriate-
ness of the method for prescribing antimicrobial therapy remains
[1,2,8–12].
The anticipations of molecular diagnostic systems becoming the
new gold standard for patient diagnosis have largely gone unmet
and blood culture still remains as the de facto method to determine
the course of patient treatment [2,8–12]. In light of the focus on
molecular diagnostics, efforts to develop rapid techniques to
directly test pathogen susceptibility are lacking [13]. In fact, we
believe direct susceptibility testing of such blood-borne pathogens
may be of greater importance than species identification via
genotyping as the selective pressures of broad-spectrum antibiotic
use have contributed to the increased incidence and virulence of
antimicrobial resistant septicemia [14–18]. Universal susceptibility
testing by genotyping for resistance is inferior to traditional
phenotypic methods, as the microorganisms must be screened for
a multitude of resistance cassettes. This approach has intrinsic
vulnerabilities as more complicated and genetically diverse
mechanisms of antimicrobial resistance have remained elusive
[18,19]. Herein, we describe a method of direct susceptibility
testing by monitoring phenotypic bacterial load via real-time PCR
of spiked blood samples post-exposure to an array of antimicro-
bials. This method combines rapid molecular diagnostic detection
with the traditional benefits of phenotypic testing to achieve
universal susceptibility analysis, minimum inhibitory concentra-
tion determination, and pathogen identification in blood in less
than 24 hours.
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Experimental Overview
The real-time PCR antibiogram utilizes antimicrobial exposure,
preanalytic removal of heme and human background DNA, and
colony PCR to assess pathogen susceptibility [20,21]. The
optimized protocol is described below in the Materials and
Methods Section. Briefly, 1 mL of spiked blood (,100 CFU/mL)
is added to 9 mL of growth medium and incubated for 9 hours in
various antibiotic environments. The sample is fractionated to
separate red blood cells that contain heme, a PCR inhibitor. The
supernatant, which consists of bacteria and mammalian cells, is
pelleted and decanted. The pellet is then resuspended in mam-
malian lysis buffer and treated with DNase. This technique
removes human DNA found in white blood cells from the sample,
thus enhancing the sensitivity of detection. This is an essential part
of this protocol as excess background human DNA can saturate
the PCR amplification curves when using intercalating fluoro-
phores. The sample is spun-down and the unseen bacterial cell
pellet is washed in reticulocyte saline (RS) buffer. Preparation
concludes by adding 2 mL of the sample directly to the PCR plate
as template. This bacterial isolation method takes approximately
2–3 hours of manual labor, but could be automated to decrease
sample preparation time and multiplexed for high-throughput
testing in a clinical diagnostic laboratory setting.
A target pathogen concentration of ,100 CFU/mL was
chosen to emulate levels found clinically in sepsis cases [22–24].
For bacteremia, greater than 50% of cases are low-grade (,10
CFU/mL) and ,25% of cases are high-grade bacteremia
(.100 CFU/mL), thus necessitating a detection sensitivity of at
least 100 CFU/mL.
The Real-time PCR Antibiogram
Real-time colony PCR is performed using universal forward
and reverse primers specific for the highly conserved region of the
16S ribosomal RNA gene sequence (Table 1) [25]. Real-time PCR
enables the comparison of bacterial load after antibiotic exposure
by monitoring the amount of 16S rDNA present. The Bio-Rad
iQ5 real-time PCR detection system used in this investigation was
determined to have a detection limit of approximately 2610
4
CFU/mL, thus necessitating an incubation time of at least
8 hours. Figure S1 depicts the serial dilutions and incubation
time curves used to determine the colony PCR detection limit to
optimize the procedure for sample preparation. The real-time
PCR antibiogram method determines susceptibility in less than
24 hours, an improvement upon traditional phenotypic methods
such as CO2 monitoring and agar dilution methods, which require
24 to 72 hours. The decreased time to detection using the real-
time PCR antibiogram method is depicted in Figure 1 and
illustrates how phenotypic response can be combined with the
diagnostic speed of PCR to yield drastically decreased detection
times of antibiotic resistance. The real-time PCR antibiogram
(middle) is determined by measuring the change in DCt values for
different antibiotics against an untreated control. Variations in
bacterial load post-exposure to an array of antibiotics are
amplified by PCR, thus allowing pathogen detection and
susceptibility to be obtained in much less time. Parameters for
the simulation were optimized using experimental data and
incubation times greater than 8+ hours allowed our detection
system to assay cultures at ,100 CFU/mL. The three-hour
horizontal dashes before amplification depict manual sample
preparation time.
Susceptibility and Minimum Inhibitory Concentration
Testing
The developed assay was performed on three strains of E. coli,
two of which are resistant, for three types of antibiotics: kana-
mycin, spectinomycin, and chloramphenicol (Figure 2 and Figure
S2). The real-time PCR antibiogram determines resistance by
monitoring the relative difference in pathogenic bacterial load
between treated and untreated blood samples. The cycle threshold
difference (DCt) is defined as:
Table 1. Universal primers for the 16S rRNA gene.




Figure 1. The real-time PCR antibiogram achieves rapid susceptibility testing of septicemia in less than 24 hours. Schematic that
illustrates how phenotypic response can be monitored with the diagnostic speed of PCR to yield drastically decreased detection times. The real-time
PCR antibiogram (middle) is determined by measuring the change in DCt values for different antibiotics against a control. Parameters for the
simulation (right) were optimized using experimental data and incubation times greater than 8+ hours allowed our detection system to assay
cultures at ,100 CFU/mL. The three-hour horizontal dashes before amplification depict manual sample preparation time.
doi:10.1371/journal.pone.0028528.g001
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All experiments were run in triplicate, normalized, and the Ct
value was defined as the cycle number in which the amplification
curve crossed 0.5. DCt values .3.0 were assigned to indicate
susceptibility, while DCt values ,3.0 designate resistance. We
observed no inhibition of PCR amplification from residual Heme
or from any of the three antibiotics. Susceptible E. coli produced
low bacterial loads when exposed to all three of the antibiotics and
large DCt values indicated susceptibility (Figure 2A and 2D).
Spectinomycin resistant E. coli produced low bacterial loads to all
the antibiotics except when incubated in the presence of
spectinomycin, thus yielding a significantly lower DCt value
(Figure 2B and 2E). Similarly, kanamycin resistant E. coli
produced the same result when incubation was performed with
kanamycin (Figure S2). The real-time PCR antibiogram matrix
summarizes the susceptibility results, as depicted in Table 2.
Comparison of spectinomycin DCt values between susceptible and
spectinomycin resistant E. coli confirmed a significant statistical
difference (Information S1 and Figure S3). Next, minimum
inhibitory concentration was determined for blood samples spiked
with E. coli susceptible to spectinomycin. The samples were
incubated in four different concentrations of spectinomycin and
there is a significant difference in the DCt value at concentrations
below the minimum inhibitory concentration (Figure 2C and 2F).
Figure 2 illustrates how the real-time PCR antibiogram can
determine the optimal patient-specific antimicrobial concentration
for administration in addition to aiding antimicrobial selection.
It is important to note that the cutoff value for DCt is dependent
upon factors intrinsic to the real-time PCR detection system
employed, such as the cycle time, amplification efficiency of the
polymerase, and range of the fluorescent detection window of the
system. Thus we aim to provide a conceptualized approach to
determining resistance that will need further clinical optimization.
We anticipate that advanced stages of sepsis will have higher DCt
values needed to indicate resistance as pathogenic load generally
correlates with the severity of sepsis (i.e. SIRS vs. sepsis vs. septic
shock) and larger pathogenic loads will have greater deviation
between patients. Cases in which there is partial antibiotic
resistance, as with efflux pump upregulation and partial resistance
to glycopeptide antibiotics conferred by the thickening of the
bacterial cell wall, MIC determination would ascertain the
antibiotic concentration or combination of antibiotics necessary
for therapy.
Pan-bacterial Detection and Identification
Given the large population of microbes that can cause sepsis,
pan-bacterialamplificationwasdemonstratedwith3Gram-negative
Figure 2. The real-time PCR antibiogram for aiding antimicrobial selection and administration. a-c) Real-time PCR amplification curves
for measuring the susceptibility of susceptible, spectinomycin resistant, and the minimum inhibitory concentration of E. coli spiked in blood.
Amplification curves were run in triplicate. d-f) The corresponding DCt values for the real-time amplification curves. DCt values .3.0 were assigned to
indicate susceptibility, while DCt values ,3.0 designate resistance. *P,0.01 for multiple comparisons by the Holm t Test. t=0 signifies initial bacterial
levels with no incubation and negative curves denote sample preparation with no bacteria. Susceptible E. coli was used for minimum inhibitory
concentration determination and 1x designates a spectinomycin concentration of 50 mg/mL.
doi:10.1371/journal.pone.0028528.g002
Table 2. Real-time PCR antibiogram matrix for susceptibility
testing.
Kanamycin Spectinomycin Chloramphenicol
Susceptible E. coli +6.2 +6.0 +7.0
Kanamycin Resistant 21.0 +6.3 +5.7
Spectinomycin Resistant +11.2 +1.0 +11.1
doi:10.1371/journal.pone.0028528.t002
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illustrated how the primers produced consistent, species-specific
amplicons (Figure 3B). The amplified 16S rDNA amplicons, which
are approximately 200-300 base pairs in length, contain hypervari-
able regions that are capable of enabling species-specific, bacterial
identification (Figure 3C). Sequenced amplicons were submitted to
the BLAST database and the original species were readily
identifiable (Figure 3D). Species identification could be equally
obtained using multiplexed molecular probes found in current
commercial diagnostic PCR systems.
Conclusion
Recent innovations in susceptibility testing have largely failed to
transcend the gold standard culture-based methods that have
dominated clinical diagnostic laboratory protocols for the past 50+
years. Susceptibility testing of septicemia relies on either extended
multi-day phenotypic methods that jeopardize patient survival or
molecular genotyping techniques that are limited by the number
of resistance cassettes the system can detect and that are unable to
detect newly emergent resistance genes. These issues have resulted
in the pervasive administration of broad-spectrum antimicrobials
and the increased incidence and virulence of antimicrobial
resistant septicemia.
By combining universal phenotypic susceptibility testing with
the rapid diagnostic capabilities of PCR, we have developed a
superior method of direct susceptibility testing. The procedure
determines susceptibility by monitoring pathogenic load with the
highly conserved 16S rRNA gene in blood samples exposed to
different antimicrobial drugs. The optimized protocol removes
heme and human background DNA from blood, which allows
standard real-time PCR detection systems to be employed with
high sensitivity (,100 CFU/mL). The real-time PCR antibiogram
achieves detection, susceptibility testing, minimum inhibitory
concentration determination, and identification in less than
24 hours. We anticipate the uptake of this technique to continue
with subsequent clinical testing and comparison to the current
standards of sepsis diagnosis and treatment.
Materials and Methods
Pre-analytic Removal of Heme and Human DNA Protocol
Defibrinated sheep blood (Hemostat Laboratories) was spiked
with serial dilutions of bacteria and plated onto LB-Agar (Fisher
Scientific) plates to determine initial bacteria concentrations in
CFU/mL. Susceptible bacteria: Escherichia coli (ATCC
No. 53338), Pseudomonas fluorescens (ATCC No. 13525), Pro-
teus vulgaris (ATCC No. 33420), Micrococcus luteus (ATCC
No. 49732), and Streptococcus lactis (ATCC No. 11454) (Fisher
Scientific), and resistant E. coli (donated by J. Christopher
Anderson Laboratory) were spiked into blood at concentrations
ranging between 50–200 CFU/mL. 1 mL of spiked blood was
added to 9 mL of LB Broth (Fisher Scientific, Miller) and grown in
a shaker at 37uC in the presence of kanamycin, spectinomycin, or
chloramphenicol (Sigma-Aldrich). The blood/LB mixture was
then fractionated with a Beckman Coulter Allegra X-22R
Figure 3. The real-time PCR antibiogram for pan-bacterial detection and identification. a) Pan-bacterial amplification illustrates universal
binding of the primers and b) melt curve analysis provides evidence that consistent, species-specific amplicons were generated. c) Amplicons run on
gel electrophoresis exhibit similar lengths of 200-300 base pairs and d) sequences submitted to the BLAST are readily identifiable.
doi:10.1371/journal.pone.0028528.g003
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enables the removal of the PCR inhibiting Heme from the sample.
9.5 mL of supernatant, which consisted of bacteria, white blood
cells, platelets, and serum, was collected and pelleted down for
10 min at 4500 rpm (4713 g). The supernatant (,9 mL), which
contained serum and platelets, was decanted and the remaining
pellet was resuspended. 125 mL of RIPA buffer (Thermo Scientific)
was added to lyse the mammalian cells, the solution was vortexed,
and incubated at 25uC for 5 min. 20 mL of DNase 10x reaction
buffer and 20 mL( 1U / mg) of DNase (Fisher Scientific) were added
to remove human background DNA. The sample was vortexed
and incubated at 37uC for 30 minutes. 20 mL of DNase stop
solution was then added to inhibit the reaction. The bacterial cells
were then pelleted from the lysate for 10 min at 4500 rpm
(4713 g). It is important to note that no actual pellet was visible
after centrifugation as the bacterial cell volume was inappreciable.
The supernatant (,600 mL) was decanted and the pellet was
washed with 0.5 mL of reticulocyte saline (RS) buffer with 25 mM
EDTA (4500 rpm, 5 min). A second wash was performed with
0.5 mL of RS buffer (4500 rpm, 5 min). The sample was
resuspended in 25 mL of RS buffer and sonicated for 1 min
before use as template for real-time PCR. Results obtained by the
real-time PCR antibiogram were verified by culture in LB broth
and on LB-agar plates with antibiotic discs (Information S1).
Reticulocyte Saline Buffer
A solution consisting of 130 mM NaCl, 7.4 mM MgCl2, and
5 mM KCl was buffered to a pH of 7.35 with 10 mM Na-HEPES.
Antibiotic 1x Concentrations
The 1x antibiotic concentrations used for the purposes of this
investigation were as follows: chloramphenicol: 25 mg/mL in
EtOH, kanamycin: 25 mg/mL in DI water, and spectinomycin:
50 mg/mL in water.
Real-time PCR
Colony PCR was performed with a Bio-Rad iQ5 Real-time
PCR Detection System and Stratagene Brilliant SYBR Green
qPCR Core Kit. The 16S rRNA gene primers (Invitrogen) used
are shown in Table 1 and a 58uC melting temperature was
determined optimal for annealing. In accordance with the
Stratagene Manual, 2 mL of template was used, taken directly
from the prepared protocol described above.
Sequencing of Amplicons
16S rDNA amplicons were purified with a QUIquick PCR
Purification Kit (Qiagen) and sequencing was performed at the
UC Berkeley DNA Sequencing Facility using a 48-capillary
Applied Biosystems 3730xl DNA Analyzer. The forward primer of
the PCR reaction was utilized as the sequencing primer and results
were analyzed using the Basic Local Alignment Search Tool
(BLAST), provided by the National Center for Biotechnology
Information (NCBI). The determined amplicon sequences are
reported in the Information S1.
Simulation of Real-time PCR Antibiogram Threshold
The simulation depicted in Fig. 1 was established using
parameters for a typical real-time PCR detection system with
decreasing polymerase efficiency, depleting reagent concentra-
tions, and the saturation of fluorescent signal. Simulation
parameters were optimized using experimental data.
Supporting Information
Figure S1 Protocol optimization for the Bio-Rad iQ5
PCR detection system. a) A limit of detection (LOD) of
2610
4 CFU/mL was determined for colony PCR, although lower
limits have been reported. b) Optimization of our experimental
protocol necessitates an incubation time of 8+ hours to
differentiate bacterial growth from the initial concentrations found
in septicemia.
(TIF)
Figure S2 Additional susceptibility testing with kana-
mycin resistant E. coli. a) Additional susceptibility testing was
performed for kanamycin resistant E. coli spiked in whole blood.
Real-time amplification curves were run in triplicate. b) The
corresponding DCt values for the real-time amplification curves.
DCt values .3.0 were assigned to indicate susceptibility, while DCt
values ,3.0 designate resistance. *P,0.05 for multiple compar-
isons by the Holm t Test. t=0 signifies initial bacterial levels
without incubation and negative curves denote sample preparation
without bacteria.
(TIF)
Figure S3 Probability Density Function for statistical
comparison of spectinomycin DCt values in Figure 2D
and 2E. A Gaussian ratio distribution was performed between the
spectinomycin and negative DCt values in both Figures 2D
(susceptible) and 2E (spectinomycin resistant). A two-sample
Kolmogorov-Smirnov test was performed in MATLAB to
compare the distributions. The null hypothesis for this test states
that the distributions are from the same, continuous distribution.
Our analysis rejects the null hypothesis at a significance level much
less than 0.001%. Thus spectinomycin DCt values between
susceptible and spectinomycin resistant E. coli confirmed a
significant statistical difference.
(TIF)
Information S1 Amplicon sequences used for BLAST
determination, verification of the real-time PCR anti-
biogram results via culture in LB broth and on LB-agar
plates with antibiotic discs, and statistical comparison
of spectinomycin DCt values between susceptible and
spectinomycin resistant E. coli in Figure 2D and 2E.
(DOC)
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